Investor Alert

Cerecor Inc.



After Hours

 --Quotes are delayed by 20 min

Jul 23, 2021, 7:59 p.m.





+0.11 +3.86%


Volume 16,298

Quotes are delayed by 20 min


Previous close

$ 2.90

$ 2.85


-0.05 -1.72%

Day low

Day high




52 week low

52 week high




Michael F. Cola

Michael F. Cola is a businessperson who has been the head of 7 different companies. He is Chairman-Governors Board at The Boys & Girls Clubs of Philadelphia and Chief Executive Officer & Director at Cerecor, Inc. Mr. Cola is also on the board of Ursinus College, SAGE Therapeutics, Inc. and Phathom Pharmaceuticals, Inc.

In the past Michael F. Cola held the position of President-Life Sciences Group at Safeguard Scientifics, Inc., Vice President-Global Clinical Operations at AstraZeneca Plc and Vice President-Global Clinical Operations at Astra Merck, Inc. (a subsidiary of AstraZeneca Plc), Chairman for SFN Group, Inc., Chairman of Laureate Biopharmaceutical Services, Inc., Independent Director at NuPathe, Inc., Chairman at Clarient, Inc., President, Chief Executive Officer & Director at Aevi Genomic Medicine, Inc., President-Specialty Pharmaceuticals at Shire Plc and Executive Vice President-Therapeutic Area Business at Shire Plc.

Mr. Cola received an undergraduate degree from Ursinus College and a graduate degree from Drexel University.


Date Shares Transaction Value
06/09/2020 100,000   Acquisition at $2.5 per share. 250,000
06/09/2020 100,000   Acquisition at $2.5 per share. 250,000
02/03/2020 75,746   Award at $0 per share. 0

Officers and Executives

Mr. Michael F. Cola
Chairman & Chief Executive Officer
Mr. Schond L. Greenway
Chief Financial Officer & Treasurer
Dr. Garry Arthur Neil
Chief Scientific Officer
Dr. H. Jeffrey Wilkins
Chief Medical Officer
Dr. Younok Dumortier Shin
Chief Technology Officer
Dr. Lisa Hegg
Vice President-Research & Development Programs
Mr. James A. Harrell
Chief Commercial Officer
Mr. Joseph M. Miller
Mr. Christopher Sullivan
Chief Accounting Officer
Ms. Colleen Matkowski
Vice President-Global Regulatory Affairs
Dr. Suzanne Louise Bruhn
Lead Independent Director
Dr. Gilla Kaplan
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phillip P. Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Link to MarketWatch's Slice.